MEDIPOST Co., Ltd. (078160.KQ)
KRW 12000.0
(-11.37%)
KRW 12000.0
(-11.37%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -19.39 Billion KRW | -60.64% |
| 2022 | 32.71 Billion KRW | -1264.44% |
| 2021 | 11.17 Billion KRW | -135.39% |
| 2020 | 13.34 Billion KRW | 168.52% |
| 2019 | 2.05 Billion KRW | 20.34% |
| 2018 | 1.03 Billion KRW | -4.91% |
| 2017 | 2.48 Billion KRW | 3.37% |
| 2016 | -11.02 Billion KRW | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -4.63 Billion KRW | -140.15% |
| 2024 Q2 | -8.4 Billion KRW | 143.02% |
| 2023 Q1 | -2.98 Billion KRW | -44.55% |
| 2023 Q2 | -3.56 Billion KRW | -19.44% |
| 2023 Q3 | -4.64 Billion KRW | -30.29% |
| 2023 Q4 | -8.46 Billion KRW | -82.22% |
| 2023 FY | - KRW | -60.64% |
| 2022 Q2 | -3.36 Billion KRW | -92.35% |
| 2022 FY | - KRW | -1264.44% |
| 2022 Q4 | -2.06 Billion KRW | 59.04% |
| 2022 Q3 | -5.04 Billion KRW | -50.01% |
| 2022 Q1 | -1.74 Billion KRW | -138.17% |
| 2021 Q3 | -44.83 Million KRW | 0.0% |
| 2021 FY | - KRW | -135.39% |
| 2021 Q4 | -733.61 Million KRW | -1536.42% |
| 2020 FY | - KRW | 168.52% |
| 2019 FY | - KRW | 20.34% |
| 2018 FY | - KRW | -4.91% |
| 2017 FY | - KRW | 3.37% |
| 2016 FY | - KRW | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| HLB Co., Ltd. | -172.27 Billion KRW | 88.744% |
| iNtRON Biotechnology, Inc. | -6.23 Billion KRW | -211.03% |
| BINEX Co., Ltd. | 10.87 Billion KRW | 278.363% |
| Bioneer Corporation | 10.04 Billion KRW | 293.082% |
| Anterogen.Co.,Ltd. | -437.82 Million KRW | -4329.094% |
| CrystalGenomics, Inc. | -42.79 Billion KRW | 54.689% |
| Helixmith Co., Ltd | -53 Billion KRW | 63.415% |
| Chabiotech Co.,Ltd. | 70.08 Billion KRW | 127.668% |
| Medy-Tox Inc. | 32.69 Billion KRW | 159.305% |
| Peptron, Inc. | -12.65 Billion KRW | -53.288% |
| Amicogen, Inc. | 13.95 Billion KRW | 238.977% |
| Genexine, Inc. | -40.87 Billion KRW | 52.562% |
| HLB Therapeutics Co.,Ltd. | 8.22 Billion KRW | 335.633% |
| LegoChem Biosciences, Inc. | -71.38 Billion KRW | 72.835% |
| ALTEOGEN Inc. | 440.04 Million KRW | 4506.777% |
| PharmaResearch Co., Ltd. | 104.25 Billion KRW | 118.6% |
| SillaJen, Inc. | -17.35 Billion KRW | -11.752% |
| JETEMA, Co., Ltd. | 11 Billion KRW | 276.164% |
| OliX Pharmaceuticals,Inc | -11.13 Billion KRW | -74.149% |
| Genomictree Inc. | -6.33 Billion KRW | -206.257% |
| MedPacto, Inc. | -32.6 Billion KRW | 40.532% |
| D&D Pharmatech | -9.05 Billion KRW | -114.086% |
| EASY BIO,Inc. | 24.32 Billion KRW | 179.725% |
| GI Innovation, Inc. | -51.33 Billion KRW | 62.222% |